首页
探索
nav.journalClub
趋势
更多
synapse
⌘+K
语言
简体中文
The Runx2 switch: unlocking osteoblast-related disorders through signaling pathways and non-coding RNAs | Synapse
March 3, 2026
The Runx2 switch: unlocking osteoblast-related disorders through signaling pathways and non-coding RNAs
SA
Somayeh Aslani
Hamedan University of Medical Sciences
AK
Ashkan Kalantary-Charvadeh
Hamedan University of Medical Sciences
RA
Roghayeh Abbasalipourkabir
Hamedan University of Medical Sciences
See all
Key Points
Runx2 plays a crucial role in osteoblast differentiation and activity, and its modulation can impact bone health.
The analysis highlights the involvement of non-coding RNAs in regulating runx2 expression and osteoblast function effectively.
Understanding these signaling pathways could lead to novel therapeutic interventions for osteoblast-related disorders in various populations.
This research underscores the potential for targeting runx2 and associated pathways to improve treatments for bone diseases.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Aslani et al. (Fri,) studied this question.
synapsesocial.com/papers/69a75fa3c6e9836116a2b263
https://doi.org/https://doi.org/10.1016/j.yexcr.2026.114921